Bert Windhorst

PROF.DR., (Principal Investigator)

1993 …2019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies

Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A., Jacobs, A. H., IMBI Project, Bottlaender, M., Brooks, D., Carroll, M. A., Chalon, S., Gee, A., Gerhard, A., Halldin, C., Herholz, K., Herth, M. M., Hinz, R. & 13 othersKnudsen, G. M., Kuhnast, B., López-Picón, F., Moresco, R. M., Pappata, S., Rinne, J. O., Rodriguez-Vieitez, E., Santiago-Ribeiro, M. J., Turkheimer, F. E., van Laere, K., Varrone, A., Vercouillie, J. & Winkeler, A., 1 Aug 2019, In : Alzheimer's and Dementia. 15, 8, p. 1081-1103

Research output: Contribution to journalArticleAcademicpeer-review

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

Perani, D., Iaccarino, L., Jacobs, A. H. & IMBI Brain Imaging Working Group, 1 Dec 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 327-332

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer

Kramer, G. M., Yaqub, M., Vargas, H. A., Schuit, R. C., Windhorst, A. D., van den Eertwegh, A. J. M., van der Veldt, A. A. M., Bergman, A. M., Burnazi, E. M., Lewis, J. S., Chua, S., Staton, K. D., Beattie, B. J., Humm, J. L., Davis, I. D., Weickhardt, A. J., Scott, A. M., Morris, M. J., Hoekstra, O. S. & Lammertsma, A. A., 1 Sep 2019, In : Journal of Nuclear Medicine. 60, 9, p. 1221-1227

Research output: Contribution to journalArticleAcademicpeer-review

Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N′-(3-[ 3 H] 3 methoxy phenyl)-N′-methylguanidine ([ 3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist

Metaxas, A., van Berckel, B. N. M., Klein, P. J., Verbeek, J., Nash, E. C., Kooijman, E. J. M., Renjaän, V. R. A., Golla, S. S. V., Boellaard, R., Christiaans, J. A. M., Windhorst, A. D. & Leysen, J. E., 19 Feb 2019, In : Pharmacology Research and Perspectives. 7, 1, e00458.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access